What question did this study set out to answer?

This report aims to characterize the rare occurrence of atorvastatin-associated sensorineural hearing loss.

Reversible bilateral sensorineural hearing loss associated with atorvastatin: a case report

View Full Paper

Ask AI

Bookmark

Authors

Case report reveals atorvastatin can cause reversible hearing loss in a patient, suggesting prompt identification is crucial.

This report aims to characterize the rare occurrence of atorvastatin-associated sensorineural hearing loss.
Described the clinical case of a 45-year-old woman with sensorineural hearing loss following atorvastatin use.
Confirmed diagnosis through pure-tone audiometry showing moderate bilateral hearing loss.
Monitored recovery upon discontinuation of atorvastatin and switch to rosuvastatin.
Bilateral sensorineural hearing loss improved from moderate to mild within one week of stopping atorvastatin.
At one month, audiometry confirmed normalized hearing thresholds with complete symptom resolution.
No recurrence of hearing loss was observed six months after switching to rosuvastatin.

Dari et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark